Herbal Supplement
Reumofan Plus
These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.
Most Reported Reactions
Top 10 reactions from 62 reports. One report may include multiple reactions — reaction totals may exceed the report count.
Reported Outcomes
Outcome categories as recorded in FDA reports. One report may include multiple outcomes.
| Outcome | Reports |
|---|---|
| Other Serious or Important Medical Event | 27 |
| Hospitalization | 17 |
| Other Outcome | 11 |
| Life Threatening | 7 |
| Visited Emergency Room | 6 |
| Visited a Health Care Provider | 6 |
| Disability | 5 |
| Death | 5 |
| Required Intervention | 2 |
Who Reported
Reporter demographics where available. Many reports do not include age or gender data.
Age
47 reports had age data; 15 unknown.
Gender
Reports by Year
Annual report counts from 2011–2015. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.
'11
'12
'13
'14
'15
Hover bars for exact counts.
Context about this data: Reports heavily concentrated in 2012 (71% of total). High concentration may reflect a recall, enforcement action, batch filing, or litigation-driven reporting rather than ongoing consumer use.
Data Source
This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.
View openFDA CAERS data ↗ · About our methodology · How to read this data